Identification Of High-risk Coronary Plaques By Multimodal Intravascular Imaging

NCT06681155 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-11-08

No results posted yet for this study

Summary

This study is a multicenter prospective observational clinical study, which will be conducted in 11 hospitals, and approximately 500 subjects will be enrolled. Plaque morphology and stability of non-culprit lesions were assessed by intravascular ultrasound (IVUS) and optical coherence tomography-near-infrared spectroscopy (OCT) after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). Plaques were grouped according to high-risk or non-high-risk. Clinical follow-up was conducted after PCI.

Conditions

  • Coronary Arterial Disease (CAD)
  • Acute Coronary Syndromes

Interventions

DIAGNOSTIC_TEST

Assessment of plaque morphology, structure, and stability in non-culprit lesions

Assessment of plaque morphology, structure, and stability in non-culprit lesions based on intravascular ultrasound and optical coherence tomography-near-infrared spectroscopy imaging technology.

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Yun Dai Chen, MD, PHD · People's Liberation Army General Hospital

  • Yong Zeng, PD · Beijing Anzhen Hospital

  • Lei Song · Chinese Academy of Medical Sciences, Fuwai Hospital

  • Jun Jiang, MD · Second Affiliated Hospital, School of Medicine, Zhejiang University

  • Yuquan He, MD · China-Japan Union Hospital, Jilin University

  • Wei Liu, MD · Beijing Jishuitan Hospital

  • Da Yin, MD · Shenzhen People's Hospital

  • Yining Yang, MD · People's Hospital of Xinjiang Uygur Autonomous Region

  • Jie Deng, MD · Xi'an Jiaotong University Second Affiliated Hospital

  • Ning Yang, MD · Tianjin Chest Hospital

  • Hua Yan · Wuhan Asian Heart Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-30
Primary Completion
2027-12-31
Completion
2031-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06681155 on ClinicalTrials.gov